Privia Health Group, Inc.
PRVA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -4.06 | -0.41 | 2.22 | 0.02 |
| FCF Yield | 4.68% | 3.00% | 1.87% | 1.95% |
| EV / EBITDA | 76.24 | 84.88 | -149.64 | -11.70 |
| Quality | ||||
| ROIC | 1.50% | 2.43% | -2.32% | -37.97% |
| Gross Margin | 10.19% | 9.74% | 9.93% | 6.59% |
| Cash Conversion Ratio | 7.60 | 3.50 | -3.91 | -0.29 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.57% | 19.71% | 18.41% | 7.11% |
| Free Cash Flow Growth | 35.46% | 71.31% | -13.61% | 41.55% |
| Safety | ||||
| Net Debt / EBITDA | -20.02 | -14.02 | 23.12 | 1.27 |
| Interest Coverage | 0.00 | 0.00 | -35.28 | -203.21 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 64.18 | 62.10 | 49.00 | 43.15 |